Wambeke David J.
- SEC CIK
- 0001971798
In the past year, 2 open-market purchase filings worth $737.0K and no sales.
Current role at each company
- NMTC Neuroone Medical Technologies CorpChief Business Officeras of Sep 8, 2026
- DMAC DiaMedica Therapeutics Inc.Chief Business Officeras of Jun 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $737.0K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$737.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wambeke David J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NMTC Neuroone Medical Technologies Corp
Chief Business Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)8:31 AM ET | Aug 27 | 12 daysLate | Wambeke David J.Chief Business Officer | PPurchase | +33.3K | $2.01 | +$67.0K | +20.0%200.0K after | |
| Mar 3, 2026 (view filing) | Mar 1 | 2 days | Wambeke David J.Chief Business Officer | PPurchase | +1.00M | $0.67 | +$670.0K | New position1.00M after |
DMAC DiaMedica Therapeutics Inc.
Chief Business Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2023 (view filing) | Nov 16 | Same day | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +20.0K | $2.46 | +$49.2K | +3.9%527.1K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +38.4K | $3.91 | +$150.0K | +8.2%507.1K after | |
| Apr 11, 2023 (view filing) | Apr 10 | 1 day | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +468.8K | $1.60 | +$750.0K | New position468.8K after |